$13.42
4.35% yesterday
NYSE, Apr 04, 10:00 pm CET
ISIN
US05350V1061
Symbol
AVNS

Avanos Medical, Inc. Stock price

$13.42
-1.60 10.65% 1M
-9.79 42.18% 6M
-2.50 15.70% YTD
-6.18 31.53% 1Y
-20.18 60.06% 3Y
-12.32 47.86% 5Y
-35.70 72.68% 10Y
NYSE, Closing price Fri, Apr 04 2025
-0.61 4.35%
ISIN
US05350V1061
Symbol
AVNS
Sector

Key metrics

Market capitalization $617.36m
Enterprise Value $679.86m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 8.20
EV/Sales (TTM) EV/Sales 0.99
P/S ratio (TTM) P/S ratio 0.90
P/B ratio (TTM) P/B ratio 0.74
Revenue growth (TTM) Revenue growth -2.54%
Revenue (TTM) Revenue $687.80m
EBIT (operating result TTM) EBIT $52.70m
Free Cash Flow (TTM) Free Cash Flow $82.90m
Cash position $107.70m
EPS (TTM) EPS $-8.53
P/S forward 0.92
EV/Sales forward 1.01
Short interest 2.46%
Show more

Is Avanos Medical, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Avanos Medical, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Avanos Medical, Inc. forecast:

2x Hold
100%

Analyst Opinions

2 Analysts have issued a Avanos Medical, Inc. forecast:

Hold
100%

Financial data from Avanos Medical, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
688 688
3% 3%
100%
- Direct Costs 305 305
2% 2%
44%
383 383
3% 3%
56%
- Selling and Administrative Expenses 258 258
5% 5%
38%
- Research and Development Expense 26 26
5% 5%
4%
98 98
17% 17%
14%
- Depreciation and Amortization 46 46
1% 1%
7%
EBIT (Operating Income) EBIT 53 53
29% 29%
8%
Net Profit -392 -392
534% 534%
-57%

In millions USD.

Don't miss a Thing! We will send you all news about Avanos Medical, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Avanos Medical, Inc. Stock News

Neutral
PRNewsWire
3 days ago
ZAVENTEM, Belgium , April 2, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) a global medical technology company, today announced that it will take direct responsibility for the sales and distribution of its MIC-KEY enteral feeding products in the United Kingdom, effective 25 July 2025. This strategic move reflects Avanos' commitment to prioritizing customer needs, enhancing product avai...
Neutral
PRNewsWire
19 days ago
ALPHARETTA, Ga. , March 17, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the appointment of David Pacitti as its new chief executive officer, effective April 14, 2025.
Neutral
Seeking Alpha
about one month ago
Avanos Medical Inc. (NYSE:AVNS ) Q4 2024 Earnings Conference Call February 26, 2025 9:00 AM ET Company Participants Scott Galovan - Vice President of Strategy & Corporate Development Michael Greiner - Interim Chief Executive Officer Conference Call Participants Danny Stauder - Citizens GMP Operator Good morning ladies and gentlemen. Welcome to the Avanos Fourth Quarter 2024 Earnings Call.
More Avanos Medical, Inc. News

Company Profile

Avanos Medical, Inc. is a medical technology company, which focuses on delivering clinically medical device solutions to improve patients' quality of life. Its portfolio of innovative product offerings focused on respiratory and digestive health, along with surgical and interventional pain management to improve patient outcomes and reduce the cost of care. Its brands include ON-Q, Coolife, Microcuff, MIC-Key, Quilbloc and Home pump. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.

Head office United States
CEO Michael Greiner
Employees 2,227
Founded 2014
Website www.avanos.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today